03378.HK_Providing professional financial news and data related to 03378.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

HANXBIO-B (3378.HK): Signs Strategic Cooperation and XtalPi Science Platform Licensing Deals With XtalPi

Tags：

NewTimeSpace HANXBIO-B 03378.HK

2026-09-21

HANXBIO-B(03378.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 36.88 million, loss widened by 1.22% YoY

Tags：

HANXBIO-B 03378.HK

2026-08-17

HANXBIO-B(03378.HK): Signs AI Drug R&D Cooperation Agreement with Frontier Interdisciplinary Research Center of Huazhong University of Science and Technology

Tags：

HANXBIO-B 03378.HK cooperation

2026-07-07

Hanx Biopharmaceuticals(03378.HK): Enters AI Drug R&D Collaboration with TwinEdge Bioscience

Tags：

Hanx Biopharmaceuticals 03378.HK

2026-07-03

Hanx Biopharmaceuticals-B (03378.HK) Controlling Shareholders Voluntarily Extend Lock-Up by 12 Months

Tags：

Hanx Biopharmaceuticals-B 03378.HK Extend Lock-Up

2026-06-24

HANXBIO-B(03378.HK) Included in FTSE Global Micro Cap Index

Tags：

HANXBIO-B 03378.HK FTSE Russell

2026-06-22

HANXBIO-B(03378.HK): Research Results of Four Innovative Drugs to Be Presented at AACR 2026

Tags：

HANXBIO-B 03378.HK AACR

2026-04-10

NewTimeSpace | Share Price Rebounds Over 70% in 2026, Core Products and Commercialization Pressures Coexist for Hanx Biopharmaceuticals (03378.HK)

Tags：

Hanx Biopharmaceuticals 03378.HK NewTimeSpace

2026-03-27

Scan QR Code

Download App